Flavonoids in Sepsis: Mechanistic Modulation of Inflammatory Pathways and Therapeutic Potential-A Systematic Review of Preclinical Studies
Journal of Society Medicine · 31.05.2026 · 5 (5) · 157-172
DOI: 10.71197/jsocmed.v5i5.255 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Society Medicine, online erschienen am 31.05.2026. Verfasst von Yunita Dewani und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Introduction
Sepsis is a life-threatening syndrome driven by dysregulated host immunity, excessive inflammation, oxidative stress, endothelial injury, and immunosuppression. Flavonoids are bioactive polyphenols with anti-inflammatory and antioxidant effects; however, their therapeutic relevance in sepsis remains primarily preclinical.
Methods
A systematic review was conducted using PubMed/MEDLINE, Scopus, Web of Science, and Embase to identify controlled in vivo studies that evaluated the effects of flavonoids in experimental sepsis or endotoxemia. Eligible studies compared flavonoid-treated animals with septic controls and reported survival, organ injury, inflammatory, oxidative, and mechanistic outcomes. Evidence was qualitatively synthesized, with survival findings contextualized using relevant preclinical meta-analytic data.
Results
Eighty eligible studies were synthesized, predominantly rodent models using lipopolysaccharide-induced endotoxemia or cecal ligation and puncture. More than 30 flavonoids have been reported, including quercetin, kaempferol, luteolin, apigenin, fisetin, and orientin. Flavonoids reduce TNF-α, IL-6, IL-1β, oxidative stress, and organ injury in the pulmonary, renal, hepatic, and cardiovascular systems. Aggregated evidence suggests approximately 50% higher survival in flavonoid-treated animals. The mechanisms included NF-κB and MAPK inhibition, Nrf2/HO-1 activation, endothelial protection, and macrophage polarization. The limitations of this study include the prophylactic designs, heterogeneity, and limited clinical evidence.
Conclusion
Flavonoids exhibit consistent multi-target immunomodulatory and organ-protective effects in experimental sepsis. Translation requires standardized post-insult studies, improved bioavailability, pharmacokinetic evaluation, and early phase clinical trials.
Zitieren
APA
Dewani, Y., Rusip, G., & Simbolon, B. M. (2026). Flavonoids in Sepsis: Mechanistic Modulation of Inflammatory Pathways and Therapeutic Potential-A Systematic Review of Preclinical Studies. Journal of Society Medicine, 5(5), 157-172. https://doi.org/10.71197/jsocmed.v5i5.255
Vancouver
Dewani Y, Rusip G, Simbolon BM. Flavonoids in Sepsis: Mechanistic Modulation of Inflammatory Pathways and Therapeutic Potential-A Systematic Review of Preclinical Studies. Journal of Society Medicine. 2026;5(5):157-172. doi:10.71197/jsocmed.v5i5.255
BibTeX
@article{Dewani2026,
author = {Dewani, Yunita and Rusip, Gusbakti and Simbolon, Boyke Marthin},
title = {Flavonoids in Sepsis: Mechanistic Modulation of Inflammatory Pathways and Therapeutic Potential-A Systematic Review of Preclinical Studies},
journal = {Journal of Society Medicine},
year = {2026},
volume = {5},
number = {5},
pages = {157--172},
doi = {10.71197/jsocmed.v5i5.255}
}
EUVIMED